Key Highlights
- International Epilepsy Day (IED) is observed each year on the second Monday of February, with the 2025 focus on the theme “MyEpilepsyJourney”.
- Approximately 650 million people worldwide live with epilepsy; 80 % reside in low‑ and middle‑income nations.
- India accounts for about 10 million cases, a prevalence of 5.6‑10 per 1,000, higher in rural than urban settings.
- Stigma, limited access to antiepileptic drugs, and one‑third of patients being drug‑resistant highlight ongoing challenges.
- Prevention hinges on injury avoidance, cardiovascular health, vaccination, and hygiene practices.
Detailed Insights
Since its launch by the International League Against Epilepsy and the International Bureau for Epilepsy in 2015, IED has served as a focal point for patient narratives, policy advocacy, and public education. The 2025 edition encourages individuals to chronicle their personal journeys, thereby humanising statistical data and fostering empathy. Epidemiologically, the disorder imposes a substantial economic burden, rising from €1.610 billion in 2004 to €2.120 billion in 2010 according to European estimates. In India, the disease is disproportionately represented in agrarian regions, reflecting disparities in healthcare infrastructure and medication availability. Although modern therapeutics have improved seizure control for many, roughly 33 % of patients remain refractory, underscoring the necessity for intensified research into pathophysiology and novel interventions.
Key Concepts
- Drug‑Resistant Epilepsy: A condition where seizures persist despite adequate trials of two appropriately chosen antiepileptic drugs.
- Stigma: Social prejudice that leads to discrimination in employment, marriage, driving rights, and general social participation for people with epilepsy.
- Prevention Measures: Strategies such as head‑injury protection, cardiovascular risk reduction, immunisation against neurotropic infections, and proper food‑handling hygiene aimed at lowering the incidence of epilepsy.